Lv5
1000 积分 2022-09-20 加入
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
1天前
待确认
Pan-Cancer Molecular Biomarkers
1天前
待确认
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
1天前
待确认
Tertiary lymphoid structures in cancer
1天前
待确认
Tertiary Lymphoid Structures and Immunotherapy: Challenges and Opportunities
1天前
待确认
Tumor-Associated Tertiary Lymphoid Structures: A Cancer Biomarker and a Target for Next-generation Immunotherapy
1天前
待确认
[Next-generation diagnostic pathology]
1天前
待确认
Neoadjuvant Nivolumab and Ipilimumab in Resectable Stage III Melanoma
1天前
待确认
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial
1天前
待确认
Potent Covalent Irreversible Inhibitor of KRAS G12C IBI351 in Patients with Advanced Solid Tumors: First-In-Human Phase I Study
1天前
待确认
皖公网安备34019202002308
